Lantheus Inc.
92.63
-2.02 (-2.13%)
At close: Jan 14, 2025, 3:59 PM

Lantheus Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Mar 31, 2020Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018
DEFINITY Revenue 76.97M 78.10M 76.56M 67.34M 70.53M 68.82M 63.62M 60.74M 62.31M 58.33M 59.31M 57.64M 59.84M 55.97M 56.79M 527.00K 576.00K 569.00K 562.00K
DEFINITY Revenue Growth -1.45% +2.01% +13.70% -4.53% +2.48% +8.18% +4.74% -2.51% +6.82% -1.66% +2.91% -3.69% +6.92% -1.44% +10676.28% -8.51% +1.23% +1.25% n/a
License and Royalty Revenues Revenue 4.13M 1.33M 662.00K 438.00K 7.62M 8.53M 7.29M 5.93M 5.94M 28.87M 6.76M 5.39M 7.50M 5.19M 23.10M n/a n/a n/a n/a
License and Royalty Revenues Revenue Growth +209.59% +101.66% +51.14% -94.25% -10.69% +17.06% +22.93% -0.25% -79.42% +326.77% +25.39% -28.09% +44.55% -77.53% n/a n/a n/a n/a n/a
Other Precision Diagnostics Revenue 6.28M 5.83M 5.93M 5.74M 5.45M 5.81M 6.02M 6.17M 5.36M 5.26M 5.68M 7.56M 6.74M 6.98M n/a n/a n/a n/a n/a
Other Precision Diagnostics Revenue Growth +7.85% -1.80% +3.34% +5.24% -6.08% -3.57% -2.48% +15.14% +1.86% -7.37% -24.84% +12.18% -3.47% n/a n/a n/a n/a n/a n/a
PYLARIFY Revenue 259.76M 273.25M 258.87M 215.43M 210.52M 195.47M 160.64M 143.75M 130.23M 92.78M 35.68M 96.68M 93.56M 87.32M n/a n/a n/a n/a n/a
PYLARIFY Revenue Growth -4.94% +5.56% +20.17% +2.33% +7.70% +21.68% +11.75% +10.38% +40.37% +160.00% -63.09% +3.33% +7.15% n/a n/a n/a n/a n/a n/a
Product Revenue 374.60M 392.76M 369.31M 319.51M 314.08M 292.26M 161.56M 233.37M 217.78M 180.01M 6.84M 8.89M 2.81M 1.50M n/a n/a n/a n/a n/a
Product Revenue Growth -4.62% +6.35% +15.59% +1.73% +7.47% +80.90% -30.77% +7.16% +20.98% +2530.94% -23.04% +216.15% +87.47% n/a n/a n/a n/a n/a n/a
Radiopharmaceutical Oncology Revenue 259.76M 273.25M 259.25M 216.28M 211.34M 196.19M 7.24M 144.68M 131.16M 94.10M 22.04M 5.30M 7.90M 5.25M n/a n/a n/a n/a n/a
Radiopharmaceutical Oncology Revenue Growth -4.94% +5.40% +19.87% +2.34% +7.72% +2610.14% -95.00% +10.31% +39.38% +326.95% +315.55% -32.83% +50.29% n/a n/a n/a n/a n/a n/a
Strategic Partnerships And Other Revenue 15.25M 8.72M 6.51M 7.32M 12.78M 8.98M 24.73M 5.60M 5.45M 28.58M 87.04M 22.68M 23.77M 22.80M n/a n/a n/a n/a n/a
Strategic Partnerships And Other Revenue Growth +74.80% +34.00% -11.08% -42.72% +42.35% -63.68% +341.44% +2.70% -80.92% -67.17% +283.76% -4.59% +4.26% n/a n/a n/a n/a n/a n/a
Techne Lite Revenue 20.48M 28.19M 21.71M 23.27M 21.59M 20.99M 94.37M 22.09M 19.44M 22.61M n/a 87.88M 90.36M 85.75M n/a n/a n/a n/a n/a
Techne Lite Revenue Growth -27.34% +29.81% -6.69% +7.77% +2.90% -77.76% +327.11% +13.65% -14.00% n/a n/a -2.74% +5.37% n/a n/a n/a n/a n/a n/a
Total Precision Diagnostics Revenue 103.73M 112.11M 104.21M 96.35M 97.58M 95.62M n/a 89.01M 87.11M 86.20M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Precision Diagnostics Revenue Growth -7.48% +7.58% +8.16% -1.26% +2.05% n/a n/a +2.18% +1.06% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2020Dec 31, 2019
Us Segment Revenue 294.80M 72.53M
Us Segment Revenue Growth +306.42% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 84.23M 92.54M 93.44M 75.56M 73.14M 62.61M 55.89M 66.62M 49.17M 60.09M 57.94M 81.95M 45.74M 60.81M 30.31M 26.54M 29.83M 26.98M 26.83M 27.69M 28.21M 24.24M 22.99M 22.35M 24.09M 23.70M 23.18M 24.72M 22.15M 22.81M 22.48M 18.68M 18.80M 19.08M 18.82M 17.93M 17.84M 24.67M 18.20M
Selling, General, and Administrative Revenue Growth -8.98% -0.96% +23.67% +3.31% +16.82% +12.02% -16.11% +35.48% -18.17% +3.71% -29.30% +79.15% -24.77% +100.61% +14.20% -11.01% +10.57% +0.54% -3.12% -1.84% +16.38% +5.46% +2.84% -7.21% +1.61% +2.25% -6.20% +11.58% -2.87% +1.43% +20.39% -0.64% -1.49% +1.39% +4.98% +0.49% -27.70% +35.60% n/a
Research and Development Revenue 24.15M 60.60M 48.02M 16.82M 14.45M 15.90M 30.53M 272.23M 12.52M 14.73M 12.20M 11.29M 11.25M 12.06M 10.36M 12.64M 11.68M 4.42M 4.05M 4.43M 4.86M 5.79M 4.93M 4.55M 4.32M 4.21M 3.99M 3.98M 3.55M 5.24M 5.35M 3.71M 2.85M 2.61M 3.04M 3.07M 2.46M 2.64M 6.20M
Research and Development Revenue Growth -60.15% +26.19% +185.45% +16.43% -9.13% -47.92% -88.78% +2074.85% -15.05% +20.75% +8.06% +0.36% -6.71% +16.42% -18.03% +8.17% +164.46% +9.14% -8.71% -8.77% -16.13% +17.57% +8.31% +5.44% +2.40% +5.67% +0.33% +11.87% -32.23% -2.00% +44.23% +30.22% +9.24% -14.10% -0.98% +24.74% -6.82% -57.42% n/a
Sales and Marketing Revenue 43.72M 45.03M 45.55M 35.26M 37.40M 36.46M 32.62M 26.98M 25.41M 27.49M 20.35M 19.42M 17.20M 17.63M 14.17M 12.86M 11.61M 6.30M 10.13M 10.39M 10.15M 10.95M 10.40M 9.91M 10.48M 12.13M 10.64M 10.42M 10.07M 11.60M 10.21M 8.69M 8.71M 9.84M 9.31M 7.81M 8.63M 9.23M 9.07M
Sales and Marketing Revenue Growth -2.92% -1.12% +29.16% -5.71% +2.59% +11.77% +20.88% +6.17% -7.56% +35.07% +4.79% +12.96% -2.47% +24.40% +10.24% +10.75% +84.12% -37.76% -2.52% +2.37% -7.28% +5.30% +4.90% -5.41% -13.62% +14.00% +2.08% +3.45% -13.17% +13.60% +17.59% -0.23% -11.55% +5.76% +19.23% -9.58% -6.46% +1.73% n/a